{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:14:38Z","timestamp":1793042078301,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1614,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Few studies have evaluated the risk of cancers other than hepatocellular carcinoma associated with hepatitis B virus (HBV) infection. This study aimed to estimate incidence rates of intrahepatic cholangiocarcinoma (ICC) and non-Hodgkin lymphoma (NHL) and its major subtypes in a nationwide cohort of parous women and to assess their associations with chronic HBV infection. We conducted a cohort study including 1,782,401 pregnant Taiwanese women whose HBV serostatus was obtained from the National Hepatitis B Vaccination Registry. Newly diagnosed ICCs and NHLs were ascertained through data linkage with the National Cancer Registry. Risks of ICC and NHL were assessed using Cox proportional hazards regression models. After a mean of 6.91 years of follow-up, there were 18 cases of ICC and 192 cases of NHL, including 99 cases of diffuse large B-cell lymphoma (DLBCL). Incidence rates of ICC were 0.09 and 0.43 per 100,000 person-years, respectively, among women who were hepatitis B surface antigen (HBsAg)-seronegative and HBsAg-seropositive, showing an age-adjusted hazard ratio (HRadj) (95% confidence interval [CI]) of 4.80 (1.88-12.20). The incidence rates of NHL overall for HBsAg-seronegative and HBsAg-seropositive women were 1.23 and 3.18 per 100,000 person-years, respectively, with an HRadj (95% CI) of 2.63 (1.95-3.54). Among NHL subtypes, HBsAg-seropositive women had an increased risk of DLBCL compared with those who were HBsAg-seronegative (incidence rates: 1.81 and 0.60 per 100,000 person-years, respectively; HRadj [95% CI]: 3.09 [2.06-4.64]). The significantly increased risk was not observed for other specific subtypes of NHL.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusions:\n                                 <\/jats:bold>\n                                 <jats:bold>Chronic HBV infection was associated with an increased risk of ICC and DLBCL in women. Our data suggested a possible etiological role of HBV in the development of ICC and specific subtypes of NHL. (HEPATOLOGY 2011;)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.24150","type":"journal-article","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T00:06:24Z","timestamp":1294704384000},"page":"1217-1225","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":80,"title":["Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan"],"prefix":"10.1097","volume":"53","author":[{"given":"Chyng-Wen","family":"Fwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Chu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-Lin","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenrad E.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu-Sung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manning","family":"Feinleib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20241104","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan.","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"R2-17-20241104","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens. Part B. Biological agents.","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"R3-17-20241104","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1572-0241.2008.01796.x","article-title":"Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.","volume":"103","author":"Lee","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R4-17-20241104","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3748\/wjg.14.632","article-title":"Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China.","volume":"14","author":"Zhou","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R5-17-20241104","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.bjc.6605063","article-title":"Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma.","volume":"100","author":"Lee","year":"2009","journal-title":"Br J Cancer"},{"key":"R6-17-20241104","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1349-7006.2002.tb01280.x","article-title":"Hepatitis B virus infection and B-cell non-Hodgkins lymphoma in a hepatitis B endemic area: a case-control study.","volume":"93","author":"Kim","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"R7-17-20241104","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.20137","article-title":"Non-Hodgkins lymphoma and hepatitis C virus: a case-control study from northern and southern Italy.","volume":"110","author":"Talamini","year":"2004","journal-title":"Int J Cancer"},{"key":"R8-17-20241104","first-page":"554","article-title":"High prevalence of hepatitis B virus infection in B-cell non-Hodgkins lymphoma.","volume":"91","author":"Marcucci","year":"2006","journal-title":"Haematologica"},{"key":"R9-17-20241104","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/cncr.22549","article-title":"High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers.","volume":"109","author":"Wang","year":"2007","journal-title":"Cancer"},{"key":"R10-17-20241104","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jmv.21168","article-title":"High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkins lymphoma in Korea.","volume":"80","author":"Park","year":"2008","journal-title":"J Med Virol"},{"key":"R12-17-20241104","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.21642","article-title":"Incidence of non-Hodgkins lymphoma among individuals with chronic hepatitis B virus infection.","volume":"46","author":"Ulcickas Yood","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R13-17-20241104","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1470-2045(10)70167-4","article-title":"Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study.","volume":"11","author":"Engels","year":"2010","journal-title":"Lancet Oncol"},{"key":"R14-17-20241104","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2006.02.014","article-title":"Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study.","volume":"45","author":"Amin","year":"2006","journal-title":"J Hepatol"},{"key":"R15-17-20241104","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1158\/1055-9965.EPI-08-0408","article-title":"Hematopoietic malignancies associated with viral and alcoholic hepatitis.","volume":"17","author":"Anderson","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R16-17-20241104","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/jnci\/djp146","article-title":"Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.","volume":"101","author":"Fwu","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R17-17-20241104","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/epirev\/mxj010","article-title":"Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.","volume":"28","author":"Chien","year":"2006","journal-title":"Epidemiol Rev"},{"key":"R18-17-20241104","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/jama.1987.03390190075023","article-title":"A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers.","volume":"257","author":"Chen","year":"1987","journal-title":"JAMA"},{"issue":"Suppl 1","key":"R19-17-20241104","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0264-410X(99)00460-0","article-title":"Nationwide vaccination: a success story in Taiwan.","volume":"18","author":"Huang","year":"2000","journal-title":"Vaccine"},{"key":"R21-17-20241104","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ije\/29.2.336","article-title":"Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics.","volume":"29","author":"Lu","year":"2000","journal-title":"Int J Epidemiol"},{"key":"R22-17-20241104","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood-2006-11-051672","article-title":"Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).","volume":"110","author":"Morton","year":"2007","journal-title":"Blood"},{"key":"R23-17-20241104","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.humpath.2006.04.012","article-title":"Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.","volume":"37","author":"Perumal","year":"2006","journal-title":"Hum Pathol"},{"key":"R24-17-20241104","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma.","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin Liver Dis"},{"key":"R25-17-20241104","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.","volume":"5","author":"Welzel","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R26-17-20241104","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.22606","article-title":"Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans.","volume":"49","author":"El-Serag","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R27-17-20241104","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/ijc.23251","article-title":"Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China.","volume":"122","author":"Hsing","year":"2008","journal-title":"Int J Cancer"},{"key":"R28-17-20241104","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/651231","article-title":"Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan.","volume":"201","author":"Fwu","year":"2010","journal-title":"J Infect Dis"},{"key":"R29-17-20241104","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/1055-9965.EPI-06-1056","article-title":"Infectious agents as causes of non-Hodgkin lymphoma.","volume":"16","author":"Engels","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R30-17-20241104","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0168-8278(86)80152-0","article-title":"Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease.","volume":"3","author":"Pasquinelli","year":"1986","journal-title":"J Hepatol"},{"key":"R32-17-20241104","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(07)60291-8","article-title":"HIV-1 in Taiwan.","volume":"369","author":"Chen","year":"2007","journal-title":"Lancet"},{"key":"R33-17-20241104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1521\/aeap.16.3.5.53.35530","article-title":"Update and projection on HIVAIDS in Taiwan.","volume":"16","author":"Twu","year":"2004","journal-title":"AIDS Educ Prev"},{"key":"R34-17-20241104","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jmv.1890460314","article-title":"Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan.","volume":"46","author":"Chen","year":"1995","journal-title":"J Med Virol"},{"key":"R35-17-20241104","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jmv.1097","article-title":"Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors.","volume":"65","author":"Sun","year":"2001","journal-title":"J Med Virol"},{"key":"R36-17-20241104","first-page":"227","article-title":"Hepatitis C virus infection: an overview.","volume":"34","author":"Hwang","year":"2001","journal-title":"J Microbiol Immunol Infect"},{"key":"R38-17-20241104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"R39-17-20241104","first-page":"423","article-title":"Hepatitis B virus infection and chronic liver disease in Taiwan.","volume":"25","author":"Chen","year":"1978","journal-title":"Acta Hepatogastroenterol (Stuttg)"},{"key":"R40-17-20241104","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.8211155","article-title":"From hepatitis to hepatoma: lessons from type B viral hepatitis.","volume":"262","author":"Chen","year":"1993","journal-title":"Science"},{"key":"R41-17-20241104","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jnci\/dji043","article-title":"Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.","volume":"97","author":"Yu","year":"2005","journal-title":"J Natl Cancer Inst"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.24150","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201104000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T17:03:16Z","timestamp":1730739796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201104000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.24150","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}